JP2009523006A5 - - Google Patents

Download PDF

Info

Publication number
JP2009523006A5
JP2009523006A5 JP2007511679A JP2007511679A JP2009523006A5 JP 2009523006 A5 JP2009523006 A5 JP 2009523006A5 JP 2007511679 A JP2007511679 A JP 2007511679A JP 2007511679 A JP2007511679 A JP 2007511679A JP 2009523006 A5 JP2009523006 A5 JP 2009523006A5
Authority
JP
Japan
Prior art keywords
seq
snp
risk
polynucleotide
individual
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2007511679A
Other languages
English (en)
Japanese (ja)
Other versions
JP2009523006A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2005/016076 external-priority patent/WO2005110039A2/en
Publication of JP2009523006A publication Critical patent/JP2009523006A/ja
Publication of JP2009523006A5 publication Critical patent/JP2009523006A5/ja
Pending legal-status Critical Current

Links

JP2007511679A 2004-05-07 2005-05-09 脈管疾患に関連する遺伝的多型、その検出方法および使用 Pending JP2009523006A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US56884504P 2004-05-07 2004-05-07
US62593604P 2004-11-09 2004-11-09
PCT/US2005/016076 WO2005110039A2 (en) 2004-05-07 2005-05-09 Genetic polymorphisms associated with vascular diseases, methods of detection and uses thereof

Publications (2)

Publication Number Publication Date
JP2009523006A JP2009523006A (ja) 2009-06-18
JP2009523006A5 true JP2009523006A5 (enExample) 2009-07-30

Family

ID=35394601

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2007511679A Pending JP2009523006A (ja) 2004-05-07 2005-05-09 脈管疾患に関連する遺伝的多型、その検出方法および使用

Country Status (5)

Country Link
US (1) US20050287559A1 (enExample)
EP (1) EP1753875A2 (enExample)
JP (1) JP2009523006A (enExample)
CA (1) CA2566257A1 (enExample)
WO (1) WO2005110039A2 (enExample)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7666584B2 (en) * 2005-09-01 2010-02-23 Philadelphia Health & Education Coporation Identification of a pin specific gene and protein (PIN-1) useful as a diagnostic treatment for prostate cancer
EP2016197A4 (en) * 2006-04-21 2009-09-16 Celera GENETIC POLYMORPHISMS ASSOCIATED WITH CORONARY DISEASE, DETECTION METHODS AND JOBS
EA022610B1 (ru) * 2007-02-21 2016-02-29 Декоуд Дженетикс Ехф Способ определения предрасположенности к сердечно-сосудистым заболеваниям с применением полиморфных маркеров
US20100120045A1 (en) * 2007-04-30 2010-05-13 Decode Genetics Ehf Genetic variants useful for risk assessments of coronary artery disease and myocardial infarction
CA2686874C (en) 2007-05-09 2021-10-19 The Brigham And Women's Hospital, Inc Polymorphism in the apo(a) gene predict responsiveness to acetylsalicylic acid treatment
GB2453173A (en) 2007-09-28 2009-04-01 Dxs Ltd Polynucleotide primers
WO2015100300A2 (en) * 2013-12-23 2015-07-02 Duke University Methods for diagnosing and treating copper-dependent diseases
US10829560B2 (en) 2015-04-20 2020-11-10 Consejo Superior De Investigaciones Cientificas Agents binding specifically to human cadherin-17, human cadherin-5, human cadherin-6 and human cadherin-20 RGD motif
EA202190358A1 (ru) * 2018-07-31 2021-05-04 Корнелл Юниверсити Способы генной терапии для контроля функции органов
US11216742B2 (en) 2019-03-04 2022-01-04 Iocurrents, Inc. Data compression and communication using machine learning

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1612280B1 (en) * 1993-04-05 2011-08-31 University of Utah Research Foundation Diagnosis and treatment of Williams syndrome
US5658729A (en) * 1994-10-11 1997-08-19 The University Of British Columbia Method, reagent and kit for evaluating susceptibility to premature atherosclerosis
US6524795B1 (en) * 1997-03-10 2003-02-25 Interleukin Genetics, Inc. Diagnostics for cardiovascular disorders
US6210877B1 (en) * 1997-03-10 2001-04-03 Interleukin Genetics, Inc. Prediction of coronary artery disease
EP0939136A1 (en) * 1998-01-07 1999-09-01 Academisch Ziekenhuis bij de Universiteit van Amsterdam Assay for predicting the angiographic response to lipid-lowering therapy in patients
AU7350598A (en) * 1998-04-27 1999-11-16 Amsterdam Molecular Therapeutics B.V. A frequent mutation in the cystathionine beta-synthase gene increases risk for coronary artery disease
JP2003500069A (ja) * 1999-05-24 2003-01-07 インタールーキン ジェネティックス インク 再狭窄の診断及び治療薬
US6297014B1 (en) * 1999-07-02 2001-10-02 Cedars-Sinai Medical Center Genetic test to determine non-responsiveness to statin drug treatment
JP2003527099A (ja) * 1999-11-03 2003-09-16 ザイモジェネティクス，インコーポレイティド フォリスタチン関連タンパク質ｚｆｓｔａ４
AU2001240521A1 (en) * 2000-01-20 2001-07-31 Epidauros Biotechnologie Ag (ca)n polymorphisms in an intron of the endothelial nitric oxide synthase gene and their use in diagnostic and therapeutic applications
WO2002036770A2 (fr) * 2000-10-31 2002-05-10 Aventis Pharma S.A. Sequences polymorphes du gene humain abca1, leurs utilisations, les methodes et kits de detection
EP1217080A3 (en) * 2000-12-22 2004-01-28 Pfizer Products Inc. Methods, compositions and kits relating to cardiovascular disease
US20050075283A1 (en) * 2001-07-13 2005-04-07 Applera Corporation Isolated human secreted proteins, nucleic acid molecules encoding human secreted proteins, and uses thereof
EP1293569A3 (en) * 2001-09-14 2004-03-31 Research Association for Biotechnology Full-length cDNAs
JP2006510341A (ja) * 2002-02-27 2006-03-30 バイエル・ヘルスケア・アクチェンゲゼルシャフト 有害薬剤反応および薬剤効力を予測する単一ヌクレオチド多型
EP1581618A2 (en) * 2002-05-02 2005-10-05 Curagen Corporation Therapeutic polypeptides, nucleic acids encoding same, and methods of use
AU2003299817A1 (en) * 2002-12-20 2004-07-22 Applera Corporation Genetic polymorphisms associated with stenosis, methods of detection and uses thereof
EP1613774A2 (en) * 2003-03-10 2006-01-11 Applera Corporation Genetic polymorphisms associated with stenosis, methods of detection and uses thereof

Similar Documents

Publication Publication Date Title
JP2009523005A5 (enExample)
JP2009519001A5 (enExample)
JP2009509508A5 (enExample)
JP2009519703A5 (enExample)
JP2009521905A5 (enExample)
CN110719957B (zh) 用于核酸靶向富集的方法和试剂盒
JP5663491B2 (ja) 標的核酸の検出方法
WO2002077281A1 (fr) Procede de detection d'acide nucleique relatif a une maladie
JP2011507493A (ja) 固定化されたペプチド核酸プローブを使用した標的核酸の選択的標識及び検出方法｛Ｍｅｔｈｏｄｆｏｒｓｅｌｅｃｔｉｖｅｌａｂｅｌｉｎｇａｎｄｄｅｔｅｃｔｉｏｎｏｆｔａｒｇｅｔｎｕｃｌｅｉｃａｃｉｄｓｕｓｉｎｇｉｍｍｏｂｉｌｉｚｅｄｐｅｐｔｉｄｅｎｕｃｌｅｉｃａｃｉｄｐｒｏｂｅｓ｝
JP2004516806A (ja) プライマー伸長法を用いた対立遺伝子識別のためのプロセス
JP2009523006A5 (enExample)
JP2006521812A5 (enExample)
KR101825121B1 (ko) Ｐｎａ 기반의 실시간 ｐｃｒ 클램핑을 이용한 ｐｉｋ3ｃａ 돌연변이 검출 방법 및 키트
US20130023442A1 (en) Single nucleotide polymorphism for predicting recurrence of hepatocellular carcinoma
JP2007526764A (ja) アルツハイマー病の発症年齢に関連するａｐｏｅ遺伝子マーカー
Calabretta et al. Arginine-based PNA microarrays for APOE genotyping
JP2008079604A (ja) アルコール分解能と宿酔の耐性とを予測するためのプライマーセット、プローブセット、方法及びキット
young Mun et al. SNPs detection by a single-strand specific nuclease on a PNA zip-code microarray
JP4150057B2 (ja) 疾患に関連する核酸を検出する方法
CN1814794A (zh) 瘦素和瘦素受体基因多态性检测芯片及其制备方法和用途
JP2023536385A (ja) コロナウイルスを含む呼吸器ウイルスを検出する構成物および方法
JP3656952B2 (ja) 慢性関節リウマチ患者における続発性ａａ−アミロイドーシス罹患危険率の検出方法及びｓａａ１遺伝子座における一塩基多型を含む新規オリゴヌクレオチド
JP4102087B2 (ja) 疾患に関連する核酸を検出する方法
JP2008545387A (ja) 心血管疾患診断のための方法及び構成
JP2005245272A (ja) アルコール脱水素酵素遺伝子多型の簡易検出方法および検出用試薬